ranitidine has been researched along with Dyskinesia, Drug-Induced in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, MR; Ahmed, MS; Jayakumar, M; Job, JK; Li, EH; Ohtsu, H; Pittenger, C; Rajadas, J; Tao, J; Zamaleeva, AI | 1 |
| Canivet, JL; Damas, P; Fouddah, A | 1 |
3 other study(ies) available for ranitidine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Pharmacological antagonism of histamine H2R ameliorated L-DOPA-induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; G-Protein-Coupled Receptor Kinase 3; Histamine H2 Antagonists; Levodopa; MAP Kinase Signaling System; Mice, Inbred C57BL; Parkinson Disease; Proto-Oncogene Proteins c-fos; Ranitidine; Receptors, Histamine H2 | 2019 |
Quality problems that result in adverse outcomes provide opportunities for quality improvement.
Topics: Adult; Anti-Ulcer Agents; Antiemetics; Continuity of Patient Care; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Gastroesophageal Reflux; Humans; Metoclopramide; Ranitidine; Risk Management; Total Quality Management | 1996 |
[Clinical case of the month. Severe dyskinetic syndrome induced by ranitidine].
Topics: Aged; Dyskinesia, Drug-Induced; Humans; Male; Ranitidine; Severity of Illness Index; Syndrome | 2001 |